15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe

2 years ago Posted By : User Ref No: WURUR122045 0
  • Image
  • TypeConference
  • Image
  • Location London, United Kingdom
  • Price
  • Date 10-01-2023 - 12-01-2023
15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe, London, United Kingdom
Conference Title
15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe
Event Type
Conference
Conference Date
10-01-2023 to 12-01-2023
Location
London, United Kingdom
Organization Name / Organize By
SAE Media group
Organizing/Related Departments
SAE Media group
Organization Type
Event Organizing Company
ConferenceCategory
Both (Technical & Non Technical)
ConferenceLevel
All (State/Province/Region, National & International)
Related Industries

Medical/Healthcare/Hospital

Location
London, United Kingdom

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:
. Novel Drug Products and Large Volume Delivery
. Sustainability for Injectable Delivery Devices
. Primary Packaging Development
. Connected Drug Delivery Devices

Topics of discussion will include the latest updates in the combination product regulatory framework, insights into the evolving digital health landscape for connected delivery devices, considerations for the development of primary packaging, utilising platform technology, the delivery of novel drug formulations and large volume drug products, patient centric approaches to device design as well as sustainable approaches for device development.

This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. 

Benefits of Attending:
. Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market
. Hear about new technological advances in the delivery of large volume drugs
. Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives
. Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health
. Delve into the considerations for material components for the development of primary packaging
. Gain insight into how big pharma are incorporating sustainable approaches into drug device design

Who should attend:
Advanz Pharma; AstraZeneca; Balda Medical GmbH and Co. KG; Bayer AG; Bayer Pharma; BD Medical; BD Medical - Pharmaceutical Systems; Becton Dickinson (BD); Boehringer Ingelheim; Boehringer Ingelheim GmbH and Co. KG; Boehringer Ingelheim Pharma GmbH and CO KG; Boehringer Ingelheim Pharma Gmbh and Co. Kg; BSI; BSI Group; Chiesi Ltd; Crux Product Design Ltd; DCA Design International; Device Development; Dr.Reddys; GlaxoSmithKline; GSK; Hoffmann-La Roche; Horizon Therapeutics GmbH; Ichnos Sciences; Janssen Pharmaceutical Companies; Johnson and Johnson; Johnson and Johnson (Janssen Pharmaceutical); Medincell; Merck Group; Midas Pharma Gmbh; Nemera; Novartis; Novo Nordisk; Novo Nordisk A/S; Owen Mumford; Pfizer; Pfizer UK; PharmaEssentia; Prescient Healthcare Group; RAUMEDIC AG; Sanofi; SCHOTT AG; SPM MEDICARE PVT LTD, INDIA; Sustainable Healthcare Coalition; Takeda; Teva; Teva Pharmaceuticals; Teva Pharmaceuticals Industries Ltd.; Teva, Combination Products; TUV Italia SRL; TUV SUD Japan Ltd.; TUV SUD Product Service GmbH; University of Liverpool; University of Southern Denmark; Zeon Europe GmbH; Zeon Specialty Materials;

SAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages. 
For details, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or [email protected] 
For all delegate enquiries, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or [email protected] 


About SAE Media Group Conferences: 
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

Registration Fees
Available
Registration Fees Details
General Admission: GBP 1999.00
Registration Ways
Website
Address/Venue
TBC London  United Kingdom 
Contact
Richard Jones

[email protected]

   +442078276088